NUCLEOLIN and breast carcinoma: Following previous results obtained in breast cancer [20,33], and in order to validate nucleolin as a therapeutic target in ovarian cancer, its expression was assessed in SKOV-3, TOV-112D and OVCAR-3 human ovarian cancer cell lines.